SERAFAST absorbable violet (6/0) DS-15 needle of 70 CM box of 24 sutures - Serag & Wiessner (JO073213) - Delynov

What is violet absorbable SERAFAST (6/0)?

SERAFAST by the brand Serag-Wiessner is a monofilament, synthetic, and absorbable surgical suture medical device. This thread is developed from a segmented copolymer combining glycolide and e-caprolactone. Its monofilament structure offers a smooth surface, thereby reducing the risks of tissue trauma during needle passage and limiting bacterial adherence compared to braided threads. Presented here in 6/0 calibre with a length of 70cm, it is dyed violet (D+C No 2 dye) to ensure optimal visibility for the practitioner during the surgical act. This device meets the requirements of the European Pharmacopoeia concerning sterile synthetic absorbable monofilament sutures.

What are the clinical indications for this Serag-Wiessner suture?

In oral surgery and implantology, SERAFAST is specifically indicated for soft tissue adaptation or performing ligatures when the use of a fast-absorbing material is required. Its support profile is adapted to clinical situations where mechanical stability is only necessary for a short period, typically up to 2 weeks. It is perfectly suitable for the closure of simple mucosal wounds or securing margins after a tooth extraction, where a rapid loss of tensile strength is desirable for patient comfort and the healing kinetics of gingival tissues.

What are the technical characteristics of the DS-15 needle?

The JO073213 suture is equipped with a technical needle referenced DS-15 by Serag-Wiessner. The code 'DS' designates a 3/8 circle needle equipped with a reverse cutting triangular point. This geometry is particularly effective for passing through dense or keratinized tissues without causing accidental tearing of the margins, as the base of the triangle is oriented towards the outside of the curvature. The number '15' indicates a needle body length of 15 mm, offering an ideal balance between maneuverability in the restricted spaces of the oral cavity and control during tissue grasping.

What are the contraindications for the use of SERAFAST?

The SERAFAST device must not be used in clinical cases requiring prolonged or lasting stability of the suture material. It is formally contraindicated for the fixation of synthetic implants, such as heart valves. Furthermore, its use is not authorized in the central cardiovascular system or the central nervous system. Biologically, this suture must not be used in patients with a known hypersensitivity or allergy to any of the components (glycolide, e-caprolactone, or violet dye). Particular attention is recommended for patients presenting delayed healing.

How does absorption occur and what are the precautions?

The absorption of SERAFAST occurs by hydrolysis. This material is designed for a rapid loss of tensile strength, making it appropriate for healing phases not exceeding 14 days. The choice of this suture must imperatively take into account the specific characteristics of the material and the requirements of the surgical technique employed. As with any foreign body, prolonged presence in infected or contaminated environments (such as saliva in an open healing zone) can influence the process. It is crucial to read the instructions carefully to adapt the knotting technique to the monofilament nature of the thread to guarantee the security of the suture points.

Who is the manufacturer and what standards are respected?

This medical device is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Germany. The product benefits from a Class III regulatory classification, testifying to its high level of requirement regarding safety and clinical performance. It bears the CE1014 marking, guaranteeing its compliance with current European directives. Manufacturing respects the European Pharmacopoeia monograph relating to sterile synthetic absorbable monofilament sutures. Each box contains 24 ready-to-use sutures, ensuring optimal traceability and sterility for surgical procedures in dental offices or hospital environments.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.